Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: protocol of a multinational, phase IV, 1-cohort prospective observational study (the POSITIVE study)

Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: protocol of a multinational, phase IV, 1-cohort prospective observational study (the POSITIVE study)

Introduction Psoriasis is a chronic inflammatory skin disease that negatively impacts the quality of life of patients and their families. However, the most commonly used decision-making tools in psoriasis, Psoriasis Area and Severity Index (PASI), Physician Global Assessment (PGA) and Dermatology Li...

Full description

Bibliographic Details
Main Authors: Matthias Augustin, Esteban Dauden, Sascha Gerdes, Philip Laws, Ulrich Mrowietz, Rachel Sommer, Elke de Jong, Gabriella Fabbrocini, Luigi Naldi, Alexander Navarini, Jo Lambert, Ziad Reguiai, Eric Massana, Teresa Obis, Ismail Kasujee
Format: Article
Language:English
Published: BMJ Publishing Group 2023-02-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/2/e060536.full

Internet

https://bmjopen.bmj.com/content/13/2/e060536.full

Similar Items